Valuation: Ipca Laboratories Limited

Market Cap 490B 5.11B 4.43B 4.18B 3.8B 7.12B 7.16B 49.87B 19.23B 249B 19.21B 18.78B 794B P/E 2027 *
32.3x
P/E 2028 * 27.6x
Enterprise Value 480B 5B 4.34B 4.09B 3.71B 6.96B 7.01B 48.79B 18.81B 243B 18.79B 18.38B 776B EV / Sales 2027 *
4.36x
EV / Sales 2028 * 3.83x
Free-Float
54.94%
Yield 2027 *
0.3%
Yield 2028 * 0.32%
1 day-1.79%
1 week-1.27%
Current month-2.07%
1 month+11.57%
3 months+21.98%
6 months+23.93%
Current year+35.83%
1 week 1,926.1
Extreme 1926.1
1,995
1 month 1,800.35
Extreme 1800.35
1,999
Current year 1,392
Extreme 1392
1,999
1 year 1,252.95
Extreme 1252.95
1,999
3 years 878.45
Extreme 878.45
1,999
5 years 670
Extreme 670
1,999
10 years 200
Extreme 200
1,999
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-1.27% - - 5.21B
-0.19%-1.15%+50.40%+92.04% 1,015B
+0.33%-2.92%+50.06%+63.19% 642B
+0.49%+2.57%+20.47%+71.21% 463B
-0.22%+1.98%+36.33%+38.93% 353B
-0.07%-9.26%+15.16%+24.78% 265B
-0.31%+0.61%+2.73%+12.04% 254B
-1.53%-14.08%+35.91%+43.21% 206B
-1.60%-7.71%-20.79%-59.60% 191B
+0.49%-3.11%+27.72%+89.12% 182B
Average -0.24%-3.35%+24.22%+41.66% 396.69B
Weighted average by Cap. -0.02%-2.21%+33.26%+57.12%

Financials

2027 *2028 *
Net sales 110B 1.15B 994M 938M 852M 1.6B 1.61B 11.19B 4.31B 55.75B 4.31B 4.21B 178B 123B 1.28B 1.11B 1.05B 950M 1.78B 1.79B 12.48B 4.81B 62.19B 4.81B 4.7B 199B
Net income 15.15B 158M 137M 129M 117M 220M 221M 1.54B 594M 7.68B 593M 580M 24.51B 17.8B 186M 161M 152M 138M 258M 260M 1.81B 698M 9.02B 697M 682M 28.81B
Net Debt -10.65B -111M -96.29M -90.9M -82.48M -155M -156M -1.08B -418M -5.4B -417M -408M -17.24B -19.96B -208M -180M -170M -155M -290M -292M -2.03B -783M -10.12B -782M -765M -32.3B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
15/09/26 ₹1,934.30 -1.79% 123,212
11/09/26 ₹1,969.50 -0.03% 20,545
10/09/26 ₹1,970.10 +0.33% 107,603
09/09/26 ₹1,963.70 -0.21% 5,626
08/09/26 ₹1,967.80 +0.44% 12,948
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,932.40INR
Average target price
1,972.28INR
Spread / Average Target
+2.06%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!